Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,560,903

« Back to Dashboard

Summary for Patent: 5,560,903

Title: Method of enhancing paramagnetism in chelates for MRI
Abstract:A diagnostic medium contains at least one physiologically well tolerated complex salt comprising an anion of a complexing acid and one or more central ion or ions of an element with an atomic number of 21 to 29, 42, 44 or 57 to 83 and, optionally, one or more physiologically biocompatible cation or cations of an inorganic and/or organic base or amino acid, optionally, with additives customary in galenic formulations, dissolved or suspended in an aqueous medium.
Inventor(s): Gries; Heinz (Berlin, DE), Rosenberg; Douwe (Berlin, DE), Weinmann; Hanns-Joachim (Berlin, DE), Speck; Ulrich (Berlin, DE), Mutzel; Wolfgang (Berlin, DE), Hoyer; Georg-Alexander (Berlin, DE), Pfeiffer; Heinrich (Berlin, DE), Renneke; Franz-Josef (Berlin, DE)
Assignee: Schering Aktiengesellschaft (Berlin, DE)
Application Number:08/462,681
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form; Formulation;
Patent PDF download available with subscription

No matches for this query

Foreign Priority and PCT Information for Patent: 5,560,903

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany31 29 906.7Jul 24, 1981
Germany33 02 410.3Jan 21, 1983
Germany34 01 052.1Jan 11, 1984

International Patent Family for Patent: 5,560,903

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria18719<disabled in preview>
Austria397465<disabled in preview>
Austria52247<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?